Gov't upscales mobile coronavirus testing units
At least 96 mobile testing units should be ready to be deployed by the start of May
27th April 2020
Latest news
New partnership to explore cellular aspect of COVID-19 infection
The groups hope to discover cellular receptors or binding proteins of COVID-19
27th April 2020
AZ/MSD's Lynparza shows survival benefit in prostate cancer patients
Results from the PROfound trial showed a statistically significant and clinically meaningful improvement in overall survival
27th April 2020
GSK's dostarlimab shows promise in endometrial cancer
The trial's primary endpoints were confirmed objective response rate and duration of response
27th April 2020
Scancell kicks off COVID-19 vaccine development
The firm's DNA vaccines target dendritic cells to stimulate high avidity T cells that survey and destroy diseased cells
24th April 2020
NICE publishes new COVID-19 guidelines
The Institute's rapid COVID-19 guidelines are being produced in collaboration with NHS England/Improvement and a cross-specialty clinical group
24th April 2020
US approves Sanofi's meningococcal vaccine
The vaccine is currently under regulatory review in Europe
24th April 2020
NICE rejects NHS funding for Portola's Ondexxya
NICE says there is “no direct evidence” that the drug is better than existing treatment
24th April 2020
WHO prematurely publishes remdesivir results
Gilead says the study was underpowered and so statistically meaningful conclusions could not be drawn
24th April 2020
Coronavirus testing expanded in England
Employers and employees will be able to book a test directly for themselves or members of their household who are experiencing symptoms
24th April 2020
AZ, Saint Luke's begin testing Farxiga for COVID-19
DARE-19 will determine whether Farxiga can hold back disease progression and reduce the risk of clinical complications and death
23rd April 2020
Pharmacists warn of issues with social distancing, PPE
Forty percent of pharmacists surveyed said they were unable to maintain social distancing from patients
23rd April 2020
EC nod for merger of Mylan and Pfizer's Upjohn division
The decision ensures that the merger between Mylan and Upjohn does not harm competition
23rd April 2020
Novartis' Jakavi bests current therapy for GvHD
REACH2 is the first Phase III study in steroid-refractory acute graft-versus-host-disease (GvHD) to have met its primary endpoint
23rd April 2020
NICE backs NHS use of Bayer's Vitrakvi via the CDF
The drug was initially considered too expensive but its cost to the NHS has been lowered
22nd April 2020
